“…These variations have been reported previously to be associated with type 2 diabetes and cardiovascular disorders: rs10010131 in wolfram syndrome 1 gene (WFS1), rs1718119 in the purinergic receptor gene (P2RX7), rs4402960 in insulin-like growth factor II mRNA-binding protein 2 gene (IGF2BP2), rs10923931 in neurogenic locus notch homolog 2 gene (NOTCH2), rs10830963 in melatonin receptor 1B gene (MTNR1B), and rs7578597 in thyroid adenoma associated (THADA). The four latter variations were associated with type 2 diabetes and cardiovascular disorders at the genome-wide significance level and the signals were reproduced (Solini et al, 2004;Saxena et al, 2007;Zeggini et al, 2007;Zeggini et al, 2008;Prokopenko et al, 2009;Saxena et al, 2012;Cheng et al, 2013;Ursu et al, 2014). Hardy-Weinberg equilibrium was tested in controls and the cut-off applied was P up to 0.05.…”